Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...

Retinal thickness could be an early indicator of diseases such as Type 2 diabetes and dementia, according to study by a team ...

US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Reduced vision, also known as vision impairment, is so common that research showed nearly 30 percent of U.S. adults 71 ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

Researchers at Australia's WEHI (Walter and Eliza Hall Institute) medical research center applied AI analysis to over 50,000 ...

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...